GlyNAC (Glycine + N-Acetylcysteine) and glutathione

What 2 graded rows on glynac (glycine + n-acetylcysteine) agree on for glutathione, and where they differ. Counted side by side, never averaged.

What the rows agree on

Each block and row is one graded row from the GlyNAC (Glycine + N-Acetylcysteine) page, with its PubMed record.

Your question

Supplement
GlyNAC (Glycine + N-Acetylcysteine) Choose another

GlyNAC (Glycine + N-Acetylcysteine) and glutathione

2 rows · 130 people

Split. 1 row found an improvement and 1 found no difference.

No difference
Improved
Each block is one evidence row, sized by how many people it enrolled, with its grade inside.
  • Grade C× 1
  • Grade D× 1
Rows
2
Trials
2
People
130

Where they differ

From the rows
Trial sizeWhen publishedGrade

The best-graded row, grade C, is a randomized trial of 114 people (2022) and found no difference.

The row that found no difference was larger: 114 people, against 16 people for the row that found an improvement.

The row that found no difference is newer (2022) than the row that found an improvement (2011).

The best grade is C among the row that found no difference, and D among the row that found an improvement.

The rows

1 improved · 1 no difference
  1. Grade DGlutathione synthesis in older adults · Improved

    Open-label trial · n 16 · 2011 · 8 older and 8 younger adults

    Dose not stated in the abstract · 2 weeks

    Supplementation raised red-cell glutathione concentration by 94.6% and its fractional synthesis rate by 78.8% in older adults, and lowered markers of oxidative stress to levels similar to younger adults.

    Row on the GlyNAC (Glycine + N-Acetylcysteine) page · PubMed 21795440 (opens PubMed)

  2. Grade CBlood glutathione in healthy older adults · No difference

    RCT · n 114 · 2022 · Healthy older adults (mean age 65)

    2.4, 4.8 or 7.2 g/day · 2 weeks

    GlyNAC was safe and well tolerated but did not raise total glutathione (the primary endpoint) or the reduced-to-oxidized glutathione ratio compared with placebo; the abstract reports a post-hoc benefit only in a subgroup with higher oxidative stress or lower baseline glutathione.

    Row on the GlyNAC (Glycine + N-Acetylcysteine) page · PubMed 35821844 (opens PubMed)

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.